Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Genetic Technologies ROA 2006-2018 | GENE

Current and historical return on assets (ROA) values for Genetic Technologies (GENE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Genetic Technologies ROA for the three months ending December 31, 2018 was 0.00%.
Genetic Technologies ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $0.00B $0.00B 0.00%
2018-06-30 $0.00B $0.01B 0.00%
2017-12-31 $0.00B $0.01B 0.00%
2017-06-30 $0.00B $0.01B 0.00%
2016-12-31 $0.00B $0.01B 0.00%
2016-06-30 $0.00B $0.01B 0.00%
2015-12-31 $0.00B $0.01B 0.00%
2015-06-30 $0.00B $0.02B 0.00%
2014-12-31 $0.00B $0.00B 0.00%
2014-06-30 $0.00B $0.01B 0.00%
2013-12-31 $0.00B $0.01B 0.00%
2013-06-30 $0.00B $0.01B 0.00%
2012-12-31 $0.00B $0.01B 0.00%
2012-06-30 $0.00B $0.02B 0.00%
2011-12-31 $0.00B $0.02B 0.00%
2011-06-30 $0.00B $0.01B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2009-12-31 $0.00B $0.01B 0.00%
2009-06-30 $0.00B $0.01B 0.00%
2008-12-31 $0.00B $0.02B 0.00%
2008-06-30 $0.00B $0.02B 0.00%
2007-12-31 $0.00B $0.03B 0.00%
2007-06-30 $0.00B $0.02B 0.00%
2006-12-31 $0.00B $0.02B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.013B $0.000B
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.392B 12.66
Gilead Sciences (GILD) United States $80.676B 10.27
Celgene (CELG) United States $66.241B 12.25
Illumina (ILMN) United States $46.818B 55.72
Biogen (BIIB) United States $44.688B 8.66
Vertex Pharmaceuticals (VRTX) United States $42.687B 57.18
Regeneron Pharmaceuticals (REGN) United States $37.478B 17.41
Alexion Pharmaceuticals (ALXN) United States $28.137B 17.44
Incyte (INCY) United States $15.924B 148.64
BioMarin Pharmaceutical (BMRN) United States $14.689B 0.00
Exact Sciences (EXAS) United States $11.546B 0.00
Seattle Genetics (SGEN) United States $11.396B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
Alnylam Pharmaceuticals (ALNY) United States $9.024B 0.00
QIAGEN (QGEN) Netherlands $8.689B 28.75
Sarepta Therapeutics (SRPT) United States $8.465B 0.00
Moderna (MRNA) United States $7.732B 0.00
Bluebird Bio (BLUE) United States $7.660B 0.00
BeiGene (BGNE) Cayman Islands $7.227B 0.00
Bio-Techne Corp (TECH) United States $7.127B 48.02
Exelixis (EXEL) United States $6.437B 14.94
Guardant Health (GH) United States $6.248B 0.00
Galapagos (GLPG) Belgium $5.840B 0.00
Amarin (AMRN) Ireland $5.703B 0.00
Alkermes (ALKS) Ireland $5.202B 0.00
Array BioPharma (ARRY) United States $4.877B 0.00
Horizon Pharma Public (HZNP) Ireland $4.537B 13.44
Ascendis Pharma (ASND) Denmark $4.502B 0.00
Spark Therapeutics (ONCE) United States $4.203B 0.00
China Biologic Products (CBPO) China $3.826B 23.70
ARGENX SE-ADR (ARGX) Netherlands $3.700B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.355B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.318B 0.00
Blueprint Medicines (BPMC) United States $3.251B 0.00
Global Blood Therapeutics (GBT) United States $3.187B 0.00
Immunomedics (IMMU) United States $3.171B 0.00
Allogene Therapeutics (ALLO) United States $3.105B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.092B 0.00
Amicus Therapeutics (FOLD) United States $2.879B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.665B 0.00
Emergent Biosolutions (EBS) United States $2.651B 22.05
Intercept Pharmaceuticals (ICPT) United States $2.647B 0.00
Denali Therapeutics (DNLI) United States $2.497B 0.00
Akcea Therapeutics (AKCA) United States $2.457B 0.00
Ligand Pharmaceuticals (LGND) United States $2.451B 18.30
Repligen (RGEN) United States $2.381B 73.24
Halozyme Therapeutics (HALO) United States $2.377B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.92
Reata Pharmaceuticals (RETA) United States $2.337B 0.00
Insmed (INSM) United States $2.286B 0.00
Genomic Health (GHDX) United States $2.266B 57.92
Arena Pharmaceuticals (ARNA) United States $2.222B 0.00
Mirati Therapeutics (MRTX) United States $2.195B 0.00
Acceleron Pharma (XLRN) United States $2.132B 0.00
UniQure (QURE) Netherlands $2.055B 0.00
Medicines (MDCO) United States $2.033B 0.00
REGENXBIO (RGNX) United States $2.003B 20.81
AnaptysBio (ANAB) United States $1.982B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.905B 0.00
MyoKardia (MYOK) United States $1.890B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.854B 0.00
NeoGenomics (NEO) United States $1.851B 150.54
Zai Lab Unsponsored ADR (ZLAB) China $1.666B 0.00
Audentes Therapeutics (BOLD) United States $1.645B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.589B 0.00
Allakos (ALLK) United States $1.552B 0.00
Atara Biotherapeutics (ATRA) United States $1.504B 0.00
Alector (ALEC) United States $1.483B 0.00
Rubius Therapeutics (RUBY) United States $1.416B 0.00
Myovant Sciences (MYOV) United Kingdom $1.367B 0.00
Innoviva (INVA) United States $1.352B 3.72
Momenta Pharmaceuticals (MNTA) United States $1.349B 0.00
Lion Biotechnologies (IOVA) United States $1.329B 0.00
InflaRx (IFRX) Germany $1.313B 0.00
Cambrex (CBM) United States $1.277B 13.74
Aimmune Therapeutics (AIMT) United States $1.274B 0.00
Puma Biotechnology (PBYI) United States $1.265B 0.00
Editas Medicine (EDIT) United States $1.263B 0.00
Sangamo Therapeutics (SGMO) United States $1.197B 0.00
Apellis Pharmaceuticals (APLS) United States $1.178B 0.00
Epizyme (EPZM) United States $1.145B 0.00
Clovis Oncology (CLVS) United States $1.102B 0.00
Gossamer Bio (GOSS) United States $1.078B 0.00
Codexis (CDXS) United States $1.056B 0.00
NGM BIOPHARMACT (NGM) United States $1.040B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.033B 0.00
Coherus BioSciences (CHRS) United States $1.022B 0.00
Fate Therapeutics (FATE) United States $1.015B 0.00
Clementia Pharmaceuticals (CMTA) Canada $1.003B 0.00
Genfit SA (GNFT) France $0.941B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.939B 0.00
WAVE Life Sciences (WVE) Singapore $0.889B 0.00
RA PHARMCTL INC (RARX) United States $0.886B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.880B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.877B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.876B 35.40
Alder BioPharmaceuticals (ALDR) United States $0.875B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.874B 0.00
Eidos Therapeutics (EIDX) United States $0.861B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.841B 0.00
Retrophin (RTRX) United States $0.837B 0.00
Cellectis (CLLS) France $0.827B 0.00
ANI Pharmaceuticals (ANIP) United States $0.818B 14.97
Twist Bioscience (TWST) United States $0.797B 0.00
Athenex (ATNX) United States $0.755B 0.00
Intellia Therapeutics (NTLA) United States $0.737B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.722B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.717B 0.00
Cara Therapeutics (CARA) United States $0.715B 0.00
Vericel (VCEL) United States $0.712B 0.00
Principia Biopharma (PRNB) United States $0.692B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.674B 0.00
Intra-Cellular Therapies (ITCI) United States $0.671B 0.00
Arvinas (ARVN) United States $0.669B 0.00
G1 THERAPEUTICS (GTHX) United States $0.659B 0.00
Osiris Therapeutics (OSIR) United States $0.656B 0.00
Precision BioSciences (DTIL) United States $0.636B 0.00
MeiraGTx Holdings (MGTX) United States $0.622B 0.00
Viking Therapeutics (VKTX) United States $0.619B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.602B 0.00
ObsEva SA (OBSV) Switzerland $0.585B 0.00
Revance Therapeutics (RVNC) United States $0.583B 0.00
Stemline Therapeutics (STML) United States $0.572B 0.00
Heska (HSKA) United States $0.568B 50.97
Zealand Pharma (ZEAL) Denmark $0.563B 6.27
Kura Oncology (KURA) United States $0.562B 0.00
Synthorx (THOR) United States $0.557B 0.00
Acorda Therapeutics (ACOR) United States $0.552B 7.15
DBV Technologies (DBVT) France $0.533B 0.00
Mesoblast (MESO) Australia $0.517B 0.00
Magenta Therapeutics (MGTA) United States $0.509B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
Zymeworks (ZYME) Canada $0.496B 0.00
Axsome Therapeutics (AXSM) United States $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.485B 0.00
AVROBIO (AVRO) United States $0.482B 0.00
Sorrento Therapeutics (SRNE) United States $0.476B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.462B 0.00
CytomX Therapeutics (CTMX) United States $0.457B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.451B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.449B 0.00
PDL BioPharma (PDLI) United States $0.443B 9.89
CYCLERION THERA (CYCN) United States $0.443B 0.00
Anika Therapeutics (ANIK) United States $0.443B 16.75
Krystal Biotech (KRYS) United States $0.441B 0.00
Cytokineticsorporated (CYTK) United States $0.440B 0.00
KALEIDO BIOSCI (KLDO) $0.439B 0.00
Scholar Rock Holding (SRRK) United States $0.439B 0.00
Five Prime Therapeutics (FPRX) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.429B 0.00
MediciNova (MNOV) United States $0.415B 0.00
Dynavax Technologies (DVAX) United States $0.412B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.408B 0.00
Gritstone Oncology (GRTS) United States $0.406B 0.00
Replimune (REPL) United States $0.402B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.402B 0.00
Abeona Therapeutics (ABEO) United States $0.393B 0.00
Kezar Life Sciences (KZR) United States $0.382B 0.00
Senesco Technologies (ELOX) United States $0.381B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Albireo Pharma (ALBO) United States $0.370B 0.00
STEALTH BIOTHER (MITO) United States $0.366B 0.00
Inovio Pharmaceuticals (INO) United States $0.363B 0.00
Adverum Biotechnologies (ADVM) United States $0.357B 0.00
PHASEBIO PHARMA (PHAS) United States $0.345B 0.00
Merus (MRUS) Netherlands $0.345B 0.00
Agenus (AGEN) United States $0.341B 0.00
BeyondSpring (BYSI) United States $0.339B 0.00
Kindred Biosciences (KIN) United States $0.337B 0.00
UNITY Biotechnology (UBX) $0.336B 0.00
BioDelivery Sciences (BDSI) United States $0.332B 0.00
Geron (GERN) United States $0.324B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.319B 0.00
AC Immune SA (ACIU) Switzerland $0.319B 0.00
XBiotech (XBIT) United States $0.312B 0.00
Solid Biosciences (SLDB) United States $0.312B 0.00
Constellation Pharmaceuticals (CNST) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.306B 0.00
Kadmon Holdings (KDMN) United States $0.302B 0.00
MannKind (MNKD) United States $0.289B 0.00
Seres Therapeutics (MCRB) United States $0.281B 0.00
LogicBio Therapeutics (LOGC) United States $0.281B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
Evelo Biosciences (EVLO) United States $0.261B 0.00
Kala Pharmaceuticals (KALA) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
Enochian BioSciences (ENOB) United States $0.255B 0.00
Urovant Sciences (UROV) United States $0.253B 0.00
Kamada (KMDA) Israel $0.252B 11.38
Eiger BioPharmaceuticals (EIGR) United States $0.251B 0.00
Novavax (NVAX) United States $0.249B 0.00
ResTORbio (TORC) United States $0.247B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
Protagonist Therapeutics (PTGX) United States $0.244B 0.00
Avid Bioservices (CDMO) United States $0.242B 0.00
Syros Pharmaceuticals (SYRS) United States $0.235B 0.00
Celcuity (CELC) United States $0.225B 0.00
Cerecor (CERC) United States $0.222B 0.00
Palatin Technologies (PTN) United States $0.221B 109.00
ChromaDex (CDXC) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.217B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.215B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.212B 0.00
OSMOTICA PHARM (OSMT) United States $0.208B 0.00
Celyad SA (CYAD) Belgium $0.208B 0.00
Intec Pharma (NTEC) Israel $0.205B 0.00
OvaScience (MLND) United States $0.205B 0.00
Athersys (ATHX) United States $0.204B 0.00
Gamida Cell (GMDA) Israel $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.202B 0.00
Synlogic (SYBX) United States $0.202B 0.00
CorMedix Inc (CRMD) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.200B 0.00
TOCAGEN INC (TOCA) United States $0.199B 0.00
Cel-Sci (CVM) United States $0.191B 0.00
Axovant Sciences (AXGT) United Kingdom $0.190B 0.00
Arbutus Biopharma (ABUS) Canada $0.189B 0.00
Pfenex (PFNX) United States $0.185B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.181B 0.00
BioTime (BTX) United States $0.179B 0.00
Cue Biopharma (CUE) United States $0.170B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Compugen (CGEN) Israel $0.169B 0.00
Verastem (VSTM) United States $0.165B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.153B 0.00
BioXcel Therapeutics (BTAI) United States $0.151B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.151B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.148B 0.00
Chiasma (CHMA) United States $0.143B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.143B 0.00
Anavex Life Sciences (AVXL) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Trevena (TRVN) United States $0.139B 0.00
Allena Pharmaceuticals (ALNA) United States $0.137B 0.00
Eton Pharmaceuticals (ETON) United States $0.135B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.128B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.122B 0.00
VolitionRX (VNRX) Singapore $0.122B 0.00
Aptinyx (APTX) United States $0.121B 0.00
Provention Bio (PRVB) United States $0.118B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.114B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.113B 0.00
XOMA (XOMA) United States $0.110B 0.00
Neothetics (EVFM) United States $0.108B 0.00
Unum Therapeutics (UMRX) United States $0.107B 0.00
Cohbar (CWBR) United States $0.105B 0.00
Catalyst Biosciences (CBIO) United States $0.104B 0.00
Selecta Biosciences (SELB) United States $0.103B 0.00
INMUNE BIO INC (INMB) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.099B 0.00
NantKwest (NK) United States $0.098B 0.00
Equillium (EQ) United States $0.095B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.094B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Signal Genetics (MGEN) United States $0.088B 0.00
Cocrystal Pharma (COCP) United States $0.085B 90.00
Applied Genetic Technologies (AGTC) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Fortress Biotech (FBIO) United States $0.083B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.082B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Alcobra (ARCT) United States $0.080B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.079B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Eyenovia (EYEN) United States $0.076B 0.00
Mustang Bio (MBIO) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
AEterna Zentaris (AEZS) United States $0.071B 17.24
OVID THERAPEUTC (OVID) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.068B 0.00
Cidara Therapeutics (CDTX) United States $0.067B 0.00
Idera Pharmaceuticals (IDRA) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.064B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Apricus Biosciences (SEEL) United States $0.062B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Evogene (EVGN) Israel $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
HOTH THERAPEUTC (HOTH) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.048B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
AZURRX BIOPHARM (AZRX) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.045B 0.00
ANCHIANO THERAP (ANCN) Israel $0.044B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Celsion (CLSN) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Zosano Pharma (ZSAN) United States $0.042B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
VIVUS (VVUS) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Arsanis (XFOR) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.032B 0.00
Sophiris Bio (SPHS) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
GTx (GTXI) United States $0.028B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
Oragenics (OGEN) United States $0.024B 0.00
Galena Biopharma (SLS) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
IMMURON LTD (IMRN) Australia $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Histogenics (HSGX) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Advaxis (ADXS) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 6.05
RestorGenex (DFFN) United States $0.011B 0.00
AmpliPhi Biosciences (APHB) United States $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Proteon Therapeutics (PRTO) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Edge Therapeutics (PDSB) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00